Identification of the Minimal Glycotope of Streptococcus pneumoniae 7F Capsular Polysaccharide using Synthetic Oligosaccharides

A Streptococcus pneumoniae Type 2 Oligosaccharide Glycoconjugate Elicits Opsonic Antibodies and Is Protective in an Animal Model of Invasive Pneumococcal Disease

(2017) Madhu Emmadi et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

The rise and fall of pneumococcal serotypes carried in the PCV era

(2017) Vanessa T. Devine et al.   VACCINE

Deciphering Antigenic Determinants of Streptococcus pneumoniae Serotype 4 Capsular Polysaccharide using Synthetic Oligosaccharides

(2016) Andreas Geissner et al.   ACS Chemical Biology

Pneumococcal Capsules and Their Types: Past, Present, and Future

(2015) K. Aaron Geno et al.   CLINICAL MICROBIOLOGY REVIEWS

Trichloroisocyanuric acid (TCCA): an efficient green reagent for activation of thioglycosides toward hydrolysis

(2013) Nabamita Basu et al.   CARBOHYDRATE RESEARCH

Effect of Remote Picolinyl and Picoloyl Substituents on the Stereoselectivity of Chemical Glycosylation

(2012) Jagodige P. Yasomanee et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Establishment of a New Human Pneumococcal Standard Reference Serum, 007sp

(2011) D. Goldblatt et al.   Clinical and Vaccine Immunology

The 13-valent pneumococcal conjugate vaccine (PCV13) elicits cross-functional opsonophagocytic killing responses in humans to Streptococcus pneumoniae serotypes 6C and 7A

(2011) David Cooper et al.   VACCINE